Innovation Pharmaceuticals Inc (IPIX)

[Lemoncat]

Prurisol has failed. It was a regrettable waste of company capital but this is biotech. It is dead and gone so let's let it rest in peace back in 2018.

Why do you say Kevetrin has failed? It passed a phase 1 safety trial, demonstrated p53 modulation in two human patients, and has very compelling pre-clinical data. It appears bio-availability will be high enough to convert to an oral drug and proceed with a large phase 2 trial. Nothing to suggest a failure.

What do either of those drugs have to do with Brilacidin which has already passed phase 2 trials in two indications? The tweak on ABSSSI has already proven successful in a very large phase 2B trial where it matched daptomycin using a single dose vs a 7-day regimen.